Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Roche Holding AG (RO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
377.80 +2.00    +0.53%
11:30:00 - Closed. Currency in CHF ( Disclaimer )
Type:  Equity
Market:  Switzerland
ISIN:  CH0012032113 
VALOR:  1203211
  • Volume: 89,019
  • Bid/Ask: 377.60 / 377.80
  • Day's Range: 371.40 - 378.00
Roche Holding 377.80 +2.00 +0.53%
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Customize

Candlestick Patterns

Time Frame
Pattern Indication
Type
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Falling Three Methods 1M Current
Doji Star Bearish 1D Current
Hanging Man 1D Current
Dragonfly Bearish 1D Current
Harami Bearish 30 Current
Harami Bullish 15 Current
Completed Patterns
Belt Hold Bearish 5H 1 May 25, 2022 03:00AM
Three Inside Up 1M 2 Mar 22
Belt Hold Bearish 15 2 May 25, 2022 11:00AM
Harami Bullish 1M 3 Feb 22
Harami Cross 1M 3 Feb 22
Evening Doji Star 1D 5 May 18, 2022
Belt Hold Bearish 5H 6 May 23, 2022 01:00AM
Engulfing Bearish 5H 6 May 23, 2022 01:00AM
Bullish Engulfing 30 6 May 25, 2022 08:30AM
Downside Gap Three Methods 1D 7 May 16, 2022
Belt Hold Bearish 15 7 May 25, 2022 09:45AM
Engulfing Bearish 1M 8 Sep 21
Upside Gap Three Methods 1M 8 Sep 21
Morning Doji Star 5H 8 May 20, 2022 03:00AM
Hanging Man 1H 8 May 25, 2022 03:00AM
Harami Bullish 30 8 May 25, 2022 07:30AM
Three Inside Up 15 8 May 25, 2022 09:30AM
Bullish doji Star 5H 9 May 19, 2022 07:00AM
Harami Bullish 15 9 May 25, 2022 09:15AM
Harami Cross 15 9 May 25, 2022 09:15AM
Belt Hold Bearish 15 10 May 25, 2022 09:00AM
Engulfing Bearish 15 10 May 25, 2022 09:00AM
Three Outside Up 15 11 May 25, 2022 08:45AM
Hanging Man 1H 12 May 24, 2022 08:00AM
Three Inside Up 30 12 May 25, 2022 05:30AM
Bullish Engulfing 15 12 May 25, 2022 08:30AM
Deliberation Bearish 1H 13 May 24, 2022 07:00AM
Doji Star Bearish 1H 13 May 24, 2022 07:00AM
Hanging Man 1H 13 May 24, 2022 07:00AM
Dragonfly Bearish 1H 13 May 24, 2022 07:00AM
Harami Bullish 30 13 May 25, 2022 05:00AM
Harami Cross 30 13 May 25, 2022 05:00AM
Engulfing Bearish 1M 15 Feb 21
Engulfing Bearish 5H 15 May 17, 2022 05:00AM
Bullish Hammer 1W 17 Jan 23, 2022
Belt Hold Bearish 30 17 May 25, 2022 03:00AM
Engulfing Bearish 30 17 May 25, 2022 03:00AM
Harami Bullish 1M 18 Nov 20
Inverted Hammer 1M 18 Nov 20
Doji Star Bearish 30 18 May 24, 2022 11:30AM
Belt Hold Bearish 15 19 May 25, 2022 06:45AM
Inverted Hammer 1M 20 Sep 20
Harami Bullish 1M 21 Aug 20
Abandoned Baby Bearish 1M 23 Jun 20
Engulfing Bearish 1M 23 Jun 20
Doji Star Bearish 1W 23 Dec 12, 2021
Inverted Hammer 1H 23 May 23, 2022 06:00AM
Doji Star Bearish 1M 24 May 20
Harami Bullish 1H 24 May 23, 2022 05:00AM
Three Inside Up 1M 25 Apr 20
Bullish Engulfing 1M 25 Apr 20
Engulfing Bearish 30 25 May 24, 2022 08:00AM
Harami Bullish 1M 26 Mar 20
Harami Cross 1M 26 Mar 20
Bullish Engulfing 5H 26 May 11, 2022 09:00AM
Belt Hold Bearish 1H 26 May 23, 2022 03:00AM
Harami Bullish 15 26 May 25, 2022 05:00AM
Harami Cross 15 26 May 25, 2022 05:00AM
Engulfing Bearish 1M 27 Feb 20
Hanging Man 30 27 May 24, 2022 07:00AM
Harami Bullish 15 29 May 25, 2022 04:15AM
Harami Cross 15 29 May 25, 2022 04:15AM
Hanging Man 30 30 May 24, 2022 05:30AM
Hanging Man 1M 31 Oct 19
Harami Cross Bearish 1H 31 May 20, 2022 07:00AM
Hanging Man 1W 32 Oct 10, 2021
Doji Star Bearish 1D 32 Apr 07, 2022
Shooting Star 30 33 May 24, 2022 04:00AM
Doji Star Bearish 1D 34 Apr 05, 2022
Three Outside Up 30 34 May 24, 2022 03:30AM
Belt Hold Bearish 15 34 May 25, 2022 03:00AM
Engulfing Bearish 15 34 May 25, 2022 03:00AM
Three Outside Up 1D 35 Apr 04, 2022
Belt Hold Bullish 30 35 May 24, 2022 03:00AM
Bullish Engulfing 30 35 May 24, 2022 03:00AM
Deliberation Bearish 15 35 May 24, 2022 11:30AM
Doji Star Bearish 15 35 May 24, 2022 11:30AM
Three Black Crows 1M 36 May 19
Belt Hold Bullish 1D 36 Apr 01, 2022
Bullish Engulfing 1D 36 Apr 01, 2022
Engulfing Bearish 1H 36 May 19, 2022 11:00AM
Bullish Hammer 5H 37 May 05, 2022 03:00AM
Engulfing Bearish 1M 41 Dec 18
Inverted Hammer 30 42 May 23, 2022 08:30AM
Harami Bullish 30 42 May 23, 2022 08:30AM
Three Inside Down 1M 44 Sep 18
Harami Bearish 1M 45 Aug 18
Harami Cross Bearish 1M 45 Aug 18
Bullish Hammer 5H 45 May 02, 2022 12:00AM
Belt Hold Bearish 15 45 May 24, 2022 09:00AM
Hanging Man 1D 48 Mar 16, 2022
Morning Doji Star 1M 49 Apr 18
Thrusting Bearish 30 49 May 23, 2022 05:00AM
Dark Cloud Cover 15 49 May 24, 2022 08:00AM
Bullish doji Star 1M 50 Mar 18
Engulfing Bearish 5H 50 Apr 28, 2022 01:00AM
Abandoned Baby Bullish 15 50 May 24, 2022 07:45AM
Three Inside Up 15 50 May 24, 2022 07:45AM
Hanging Man 1W 51 May 30, 2021
Engulfing Bearish 1H 51 May 18, 2022 05:00AM
Three Black Crows 30 51 May 23, 2022 04:00AM
Harami Bullish 15 51 May 24, 2022 07:30AM
Harami Cross 15 51 May 24, 2022 07:30AM
Downside Gap Three Methods 5H 53 Apr 27, 2022 12:00AM
Belt Hold Bearish 30 53 May 23, 2022 03:00AM
Belt Hold Bearish 15 53 May 24, 2022 07:00AM
Gravestone Doji 15 55 May 24, 2022 06:30AM
Engulfing Bearish 1W 56 Apr 25, 2021
Engulfing Bearish 30 56 May 20, 2022 10:30AM
Harami Bullish 1M 58 Jul 17
Three Black Crows 1H 58 May 17, 2022 07:00AM
Hanging Man 1W 59 Apr 04, 2021
Deliberation Bearish 5H 59 Apr 22, 2022 10:00AM
Morning Doji Star 30 59 May 20, 2022 09:00AM
Morning Star 30 59 May 20, 2022 09:00AM
Harami Cross Bearish 1D 60 Feb 28, 2022
Bullish doji Star 30 60 May 20, 2022 08:30AM
Belt Hold Bearish 15 62 May 24, 2022 04:45AM
Three Inside Up 1W 63 Mar 07, 2021
Inverted Hammer 1D 63 Feb 23, 2022
Harami Bullish 1W 64 Feb 28, 2021
Harami Cross 1W 64 Feb 28, 2021
Bullish Engulfing 1M 65 Dec 16
Bullish Hammer 5H 65 Apr 20, 2022 08:00AM
Three Outside Up 1H 65 May 16, 2022 09:00AM
Bullish Engulfing 1H 66 May 16, 2022 08:00AM
Three Inside Up 1W 67 Feb 07, 2021
Dark Cloud Cover 15 67 May 24, 2022 03:30AM
Harami Cross 1M 68 Sep 16
Harami Bullish 1W 68 Jan 31, 2021
Harami Cross 1W 68 Jan 31, 2021
Three Outside Up 1D 68 Feb 16, 2022
Bullish Engulfing 1D 69 Feb 15, 2022
Harami Bullish 1H 69 May 16, 2022 05:00AM
Belt Hold Bullish 15 69 May 24, 2022 03:00AM
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RO Comments

Write your thoughts about Roche Holding AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sherlyn Jones
Sherlyn Jones Apr 22, 2021 6:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
Ruta Rublevska
Ruta Rublevska Nov 16, 2020 3:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
13.11.2020. CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza. This CHMP recommendation brings patients with influenza one step closer to potentially benefiting from Xofluza’s oral one-dose regimen, setting adults and adolescents on the path to feeling better sooner compared to placebo,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “We believe that access to effective antivirals for influenza, and particularly their use in the prophylactic setting, could help reduce the strain of the COVID-19 pandemic on healthcare systems in Europe.
Jonny Tr
Jonny Tr May 04, 2020 8:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just like Biolidics. they get approval for Covid19 tests kits in USA
Billy Hanafi
Billy Hanafi Jan 25, 2019 10:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i dont know
edgard hajjar
edgard hajjar May 07, 2018 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is the historical price adjusted for stock splits?
Billy Hanafi
Billy Hanafi May 07, 2018 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i dont know
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email